This complimentary live program aims to equip clinicians, including endocrinologists, primary care physicians (PCPs), and advanced practice providers (APPs), with the knowledge and tools to go beyond diagnosis to improve the detection and management of X-Linked Hypophosphatemia (XLH) across the lifespan, including the use of targeted medicines, therapy monitoring, and musculoskeletal complications, to improve patients' quality of life.
- Live Webinar Date: Friday, October 16, 2026
- Time: 1:00-2:00 PM EDT
10/16/2026
10/16/2027
Upon completion of the program, participants will be able to:
- Recognize the clinical manifestations and diagnostic challenges of X-linked hypophosphatemia (XLH) across the lifespan, including interpretation of biochemical findings and identification of adult presentations that are frequently underrecognized or misdiagnosed.
- Evaluate evidence-based treatment strategies for XLH, including conventional and targeted therapies, by applying knowledge of disease pathophysiology, patient selection, safety considerations, and long-term monitoring requirements.
- Develop multidisciplinary, lifelong management plans for patients with XLH through the case-based application of strategies to monitor skeletal and functional outcomes, manage treatment-related complications, and improve the transition of care from pediatric to adult practice.
The primary target audience for this program is endocrinologists and the endocrine care team, including nurses, nurse practitioners (NPs), physician assistants (PAs), and diabetologists.
View All Rare Endocrine Disease Webinars
Steven Petak, MD, MACE
Clinical Associate Professor, Weill Cornell
Houston Methodist Hospital
Houston, TX
Aliya Khan, MD, FRCPC, FACP, FACE
Clinical Professor of Medicine
Director, Fellowship in Metabolic Bone Disease
Director, Calcium Disorders Clinic
McMaster University
Hamilton, Canada
This activity is supported by an educational grant from Kyowa Kirin.